🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is the cohort C part of a multicenter, open label Phase Ib/II cl...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-04-11
Trial ID
NCT06821503
A Phase I/II, Open-Label, Dose-Escalation and Dose-Expansion Clinical Study...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2022-08-26
Trial ID
NCT05518045
Treatments Being Tested
A Phase I/II, Open-Label, Dose Escalation and Expansion Study to Evaluate t...
Status
Terminated
Location
Ocala Oncology Center
Start Date
2022-05-26
Trial ID
NCT05255484
Treatments Being Tested
The goal of this clinical trial is to investigate the efficacy, safety and ...
Status
Unknown
Location
Shanghai Pulmonary Hospital
Start Date
2024-01-12
Trial ID
NCT06479759
Treatments Being Tested
To evaluate the efficacy and safety of LM108 plus toripalimab plusnab-pacli...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-07-10
Trial ID
NCT06387628
Treatments Being Tested
Exploring the efficacy of PD-1 inhibitor combination therapy strategies for...
Status
Not Yet Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2024-09-30
Trial ID
NCT06620822
Treatments Being Tested
This is a phase III， Multicenter, Randomized study， evaluating the efficacy...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-04-30
Trial ID
NCT07362186
Treatments Being Tested
Based on overall response rate (ORR) as assessed by the Independent Review ...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-03-26
Trial ID
NCT06873854
Treatments Being Tested
This is a first-in-human, Phase I/II, open-label, multi-centre, dose escala...
Status
Completed
Location
Blacktown Hospital
Start Date
2022-03-16
Trial ID
NCT05199753
Treatments Being Tested
This trial is part of a multicenter, open-label Phase Ib/II clinical study ...
Status
Recruiting
Location
Anhui Provincial Cancer Hospital
Start Date
2025-04-08
Trial ID
NCT06825494